Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...
Expert Rev Clin Pharmacol. 2013;6(4):443-451.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback